|
July. 17, 2026 |
|
|
July. 31, 2026 |
|
|
jRCT1050260111 |
Long-term follow-up of human (allogeneic) iPS cell-derived cardiomyocyte sheet transplantation. |
|
Long-term follow-up of human (allogeneic) iPS cell-derived cardiomyocyte sheet transplantation. |
Miyagawa Shigeru |
||
The University of Osaka Hospital |
||
2-15,Yamadaoka,Suita |
||
+81-6-6879-3154 |
||
saisentan@tissue.med.osaka-u.ac.jp |
||
Kawamura Takuji |
||
The University of Osaka Hospital |
||
2-15,Yamadaoka,Suita |
||
+81-6-6879-3154 |
||
saisentan@tissue.med.osaka-u.ac.jp |
Recruiting |
July. 17, 2026 |
||
| 10 | ||
Observational |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
Patients enrolled in either of the following studies who have received transplantation of this product |
||
none |
||
| No limit | ||
| No limit | ||
Both |
||
Heart disease |
||
ischemic cardiomyopathy,dilated cardiomyopathy |
||
D006331 |
||
Survival time |
||
1) Number and rate of clinical events of cardiac function such as death and hospitalization |
||
| None |
| Instisutional review board of Osaka university hospital | |
| 2-2, Yamadaoka, Suita, Osaka | |
+81-6-6210-8296 |
|
| rinri@hp-crc.med.osaka-u.ac.jp | |
| Approval | |
June. 10, 2026 |
Yes |
|
The deidentified individual subject data will be used for conference presentations, research article,or both. If it is provided to the sponsor, it will be shared based on the contract. |
none |